Sentinel Initiative Public Workshop - Seventh Annual

Project Title Sentinel Initiative Public Workshop - Seventh Annual
Date
Thursday, February 5, 2015
Host

Mark B. McClellan, MD, PhD, Director, Engelberg Center for Health Care Reform, Brookings Institution, Washington, DC; Gregory W. Daniel, PhD, MPH, Managing Director for Evidence Development & Innovation, Engelberg Center for Health Care Reform, Brookings Institution, Washington DC

Location
Presenters

Janet Woodcock, MD, MPH, Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD; Richard Platt, MD, MSc, Harvard Pilgrim Healthcare Institute and Harvard Medical School, Boston, MA; Marsha Reichman, PhD, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD; Michael Nguyen, MD, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD; Karla M. Miller, PharmD, BCPP, Hospital Corporation of America, Nashville, TN;  Joseph P. Drozda, MD, Mercy Health, Chesterfield, MO;  Myrl Weinberg , CAE, National Health Council, Washington, DC;  Sharon F. Terry, MA, Genetic Alliance, Washington, DC;  Robert F. Reynolds, ScD, Pfizer, Inc., New York, NY;  Troy McCall, PhD, Reagan-Udall Foundation for the FDA, Washington, DC; Marcus D. Wilson, PharmD, HealthCore, Wilmington, DE;  Rachael L. Fleurence, PhD, Patient-Centered Outcomes Research Institute, Washington, DC;  David Wheadon, MD, AstraZeneca Pharmaceuticals, New York, NY;  Claudia Vellozzi, MD, Centers for Disease Control and Prevention Division of Viral Hepatitis, Atlanta, GA; Christine K. Cassel, MD, National Quality Forum, Washington, DC